Publications by authors named "Ryu Okada"

Claim this Profile
S
Synthetic lethality of EZH2 and DNMT Inhibition suppresses neuroblastoma proliferation via MYCN destabilization.
Yuki Endo, Ryuichi P Sugino, Hisanori Takenobu, Kyosuke Mukae, Ryu Okada

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncanonical PRC1.1 targets BTG2 to retain cyclin gene expression and cell growth in neuroblastoma.
Shunpei Satoh, Mariko Hasegawa, Ryu Okada, Masayuki Haruta, Hisanori Takenobu

Oncogenesis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photoinduced Actin Aggregation Involves Cell Death: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy.
Kazuhide Sato, Tomoko Okada, Ryu Okada, Hirotoshi Yasui, Mizuki Yamada

ACS Nano· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L3MBTL2 maintains MYCN-amplified neuroblastoma cell proliferation through silencing NRIP3 and BRME1 genes.
Ryu Okada, Hisanori Takenobu, Shunpei Satoh, Ryuichi P Sugino, Ritsuko Onuki

Genes Cells· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors.
Sultana Parvin, Jesmin Akter, Hisanori Takenobu, Yutaka Katai, Shunpei Satoh, Ryu Okada

BMC Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polycomb group protein BMI1 protects neuroblastoma cells against DNA damage-induced apoptotic cell death.
Nobuhiro Akita, Ryu Okada, Kyosuke Mukae, Ryuichi P Sugino, Hisanori Takenobu

Exp Cell Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polycomb EZH1 regulates cell cycle/5-fluorouracil sensitivity of neuroblastoma cells in concert with MYCN.
Yoshitaka Shinno, Hisanori Takenobu, Ryuichi P Sugino, Yuki Endo, Ryu Okada

Cancer Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disposition of E-selectin-targeting liposomes in tumor spheroids with a perfusable vascular network.
Chanikarn Chantarasrivong, Ryu Okada, Yuuki Yamane, Xue Yang, Yuriko Higuchi

Drug Metab Pharmacokinet· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional tissue model in direct contact with an on-chip vascular bed enabled by removable membranes.
Yoshikazu Kameda, Surachada Chuaychob, Miwa Tanaka, Yang Liu, Ryu Okada

Lab Chip· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascularized cancer on a chip: The effect of perfusion on growth and drug delivery of tumor spheroid.
Yuji Nashimoto, Ryu Okada, Sanshiro Hanada, Yuichiro Arima, Koichi Nishiyama

Biomaterials· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Export of a Vibrio parahaemolyticus toxin by the Sec and type III secretion machineries in tandem.
Shigeaki Matsuda, Ryu Okada, Sarunporn Tandhavanant, Hirotaka Hiyoshi, Kazuyoshi Gotoh

Nat Microbiol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression Profile of NOTCH3 in Mouse Spermatogonia.
Ryu Okada, Megumi Fujimagari, Eri Koya, Yoshikazu Hirose, Tomomi Sato

Cells Tissues Organs· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vibrio parahaemolyticus VtrA is a membrane-bound regulator and is activated via oligomerization.
Ryu Okada, Shigeaki Matsuda, Tetsuya Iida

PLoS One· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mechanism and control of Jagged1 expression in Sertoli cells.
Ryu Okada, Taro Hara, Tomomi Sato, Nobuhiko Kojima, Yukio Nishina

Regen Ther· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between the type III effector VopO and GEF-H1 activates the RhoA-ROCK pathway.
Hirotaka Hiyoshi, Ryu Okada, Shigeaki Matsuda, Kazuyoshi Gotoh, Yukihiro Akeda

PLoS Pathog· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of Vibrio parahaemolyticus T3SS2 gene expression and function of T3SS2 effectors that modulate actin cytoskeleton.
Toshio Kodama, Hirotaka Hiyoshi, Ryu Okada, Shigeaki Matsuda, Kazuyoshi Gotoh

Cell Microbiol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Vibrio parahaemolyticus effector VopC mediates Cdc42-dependent invasion of cultured cells but is not required for pathogenicity in an animal model of infection.
Ryu Okada, Xiaohui Zhou, Hirotaka Hiyoshi, Shigeaki Matsuda, Xiang Chen

Cell Microbiol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis